Commonwealth Equity Services LLC reduced its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 52.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 10,171 shares of the medical equipment provider's stock after selling 11,269 shares during the period. Commonwealth Equity Services LLC's holdings in STERIS were worth $2,091,000 at the end of the most recent quarter.
Other hedge funds also recently added to or reduced their stakes in the company. Human Investing LLC purchased a new position in shares of STERIS in the 4th quarter valued at about $31,000. Anfield Capital Management LLC lifted its stake in STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after acquiring an additional 91 shares during the last quarter. Central Pacific Bank Trust Division grew its holdings in STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after acquiring an additional 76 shares in the last quarter. Manchester Capital Management LLC increased its position in shares of STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after purchasing an additional 137 shares during the last quarter. Finally, Quarry LP acquired a new stake in shares of STERIS in the 3rd quarter valued at $67,000. 94.69% of the stock is currently owned by institutional investors and hedge funds.
STERIS Stock Performance
Shares of STE stock traded up $4.14 during mid-day trading on Monday, hitting $227.14. 584,196 shares of the stock were exchanged, compared to its average volume of 527,809. The stock's fifty day simple moving average is $222.86 and its two-hundred day simple moving average is $221.01. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. STERIS plc has a 12-month low of $197.82 and a 12-month high of $248.24. The stock has a market capitalization of $22.32 billion, a price-to-earnings ratio of 48.22 and a beta of 0.92.
STERIS (NYSE:STE - Get Free Report) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, analysts forecast that STERIS plc will post 9.08 EPS for the current year.
STERIS Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were issued a $0.57 dividend. The ex-dividend date was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.00%. STERIS's payout ratio is 48.41%.
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on STE. Stephens reiterated an "overweight" rating and set a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. Piper Sandler upped their price objective on STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. Finally, JMP Securities reissued a "market outperform" rating and set a $265.00 target price on shares of STERIS in a research report on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $258.75.
Check Out Our Latest Stock Analysis on STE
About STERIS
(
Free Report)
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Featured Stories
Before you consider STERIS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STERIS wasn't on the list.
While STERIS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
